Advanced Search

National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Amendment Determination 2012 (No. PB 70 of 2012)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
PB 70 of 2012
National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Amendment Determination 2012
National Health Act 1953
I, STEPHEN WALDEGRAVE, Assistant Secretary (Acting), Pharmaceutical Policy Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.
Dated         20 Sep 2012
 
 
 
 
 
 
 
 
 
STEPHEN WALDEGRAVE
 
Assistant Secretary (Acting)
Pharmaceutical Policy Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
 
1              Name of Determination
       (1)     This Determination is the National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Amendment Determination 2012.
       (2)     This Determination may also be cited as PB 70 of 2012.
2              Commencement
                This Determination commences on the day after it is registered.
 
 
3              Amendments to PB 58 of 2012
Schedule 1 amends the National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Determination 2012 (PB 58 of 2012).
Schedule 1             Amendments
 
[1]      Schedule 1
 
omit:
 
1
Docetaxel
Injection set containing 1 single use vial concentrate for I.V. infusion 20 mg (anhydrous) in 0.5 mL with solvent
Injection
Taxotere
68.61
73.77
 
 
[2]      Schedule 1, After
 
25
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
Pizaccord
27.74
29.83
 
             insert:
 
25A
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
Prioten 15
27.74
29.83
 
 
[3]      Schedule 1, After
 
36
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
Pizaccord
42.67
45.88
 
             insert:
 
36A
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
Prioten 30
42.67
45.88
 
 
[4]      Schedule 1, After
 
47
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
Pizaccord
55.48
59.65
 
insert:
 
47A
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
Prioten 45
55.48
59.65
 
 
 
Note
1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.